VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IWWM-11 2022 | The role of MRD status on response evaluation in patients with Waldenström’s macroglobulinemia

Shuhua Yi, MD, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China, discusses the challenges of analyzing patient response and complete remission (CR) in Waldenström’s macroglobulinemia (WM), and further explains how measurable residual disease (MRD) may play an important role in detecting low tumor burden levels. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter